{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:15:47Z","timestamp":1791429347553,"version":"4.3.3"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T00:00:00Z","timestamp":1386633600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1038\/nrrheum.2013.185","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T12:42:44Z","timestamp":1386679364000},"page":"108-116","source":"Crossref","is-referenced-by-count":125,"title":["Ocular inflammatory diseases associated with rheumatoid arthritis"],"prefix":"10.1038","volume":"10","author":[{"given":"Mathieu","family":"Artifoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Rapha\u00ebl","family":"Rothschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Br\u00e9zin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Guillevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Pu\u00e9chal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,10]]},"reference":[{"key":"BFnrrheum2013185_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.semarthrit.2008.08.003","volume":"39","author":"LW Moreland","year":"2009","unstructured":"Moreland, L. W. & Curtis, J. R. Systemic nonarticular manifestations of rheumatoid arthritis: focus on inflammatory mechanisms. Semin. Arthritis Rheum. 39, 132\u2013143 (2009).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrrheum2013185_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1590\/S0104-42302011000300015","volume":"57","author":"DC Antero","year":"2011","unstructured":"Antero, D. C., Parra, A. G. M., Miyazaki, F. H., Gehlen, M. & Skare, T. L. Secondary Sj\u00f6gren's syndrome and disease activity of rheumatoid arthritis. Rev. Assoc. Med. Bras. 57, 319\u2013322 (2011).","journal-title":"Rev. Assoc. Med. Bras."},{"key":"BFnrrheum2013185_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ophtha.2011.07.013","volume":"119","author":"M Sainz de la Maza","year":"2012","unstructured":"Sainz de la Maza, M. et al. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology 119, 43\u201350 (2012).","journal-title":"Ophthalmology"},{"key":"BFnrrheum2013185_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0002-9394(00)00710-8","volume":"130","author":"DA Jabs","year":"2000","unstructured":"Jabs, D. A., Mudun, A., Dunn, J. P. & Marsh, M. J. Episcleritis and scleritis: clinical features and treatment results. Am. J. Ophthalmol. 130, 469\u2013476 (2000).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrrheum2013185_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.rdc.2007.08.002","volume":"33","author":"A Galor","year":"2007","unstructured":"Galor, A. & Thorne, J. E. Scleritis and peripheral ulcerative keratitis. Rheum. Dis. Clin. North Am. 33, 835\u2013854 (2007).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"BFnrrheum2013185_CR6","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1001\/archopht.1979.01020020457010","volume":"97","author":"RH Stewart","year":"1979","unstructured":"Stewart, R. H. & Kimbrough, R. L. Intraocular pressure response to topically administered fluorometholone. Arch. Ophthalmol. 97, 2139\u20132140 (1979).","journal-title":"Arch. Ophthalmol."},{"key":"BFnrrheum2013185_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ncprheum0454","volume":"3","author":"JR Smith","year":"2007","unstructured":"Smith, J. R., Mackensen, F. & Rosenbaum, J. T. Therapy insight: scleritis and its relationship to systemic autoimmune disease. Nat. Clin. Pract. Rheumatol. 3, 219\u2013226 (2007).","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"BFnrrheum2013185_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ophtha.2003.06.006","volume":"111","author":"EK Akpek","year":"2004","unstructured":"Akpek, E. K., Thorne, J. E., Qazi, F. A., Do, D. V. & Jabs, D. A. Evaluation of patients with scleritis for systemic disease. Ophthalmology 111, 501\u2013506 (2004).","journal-title":"Ophthalmology"},{"key":"BFnrrheum2013185_CR9","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1002\/art.1780381114","volume":"38","author":"X Pu\u00e9chal","year":"1995","unstructured":"Pu\u00e9chal, X. et al. Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum. 38, 1618\u20131629 (1995).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013185_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/ard.48.1.7","volume":"48","author":"CC Erhardt","year":"1989","unstructured":"Erhardt, C. C., Mumford, P. A., Venables, P. J. & Maini, R. N. Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study. Ann. Rheum. Dis. 48, 7\u201313 (1989).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2013185_CR11","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0161-6420(84)34160-4","volume":"91","author":"CS Foster","year":"1984","unstructured":"Foster, C. S., Forstot, S. L. & Wilson, L. A. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology 91, 1253\u20131263 (1984).","journal-title":"Ophthalmology"},{"key":"BFnrrheum2013185_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/bjo.60.3.163","volume":"60","author":"PG Watson","year":"1976","unstructured":"Watson, P. G. & Hayreh, S. S. Scleritis and episcleritis. Br. J. Ophthalmol. 60, 163\u2013191 (1976).","journal-title":"Br. J. Ophthalmol."},{"key":"BFnrrheum2013185_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5005\/jp\/books\/11649_7","volume-title":"The Sclera and Systemic Disorders","author":"PG Watson","year":"2012","unstructured":"Watson, P. G., Hazleman, B. L., McCluskey, P. & Pav\u00e9sio, C. E. The Sclera and Systemic Disorders 153\u2013180 (JP Medical Ltd, London, 2012)."},{"key":"BFnrrheum2013185_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0161-6420(91)32280-2","volume":"98","author":"LP Fong","year":"1991","unstructured":"Fong, L. P., Sainz de la Maza, M., Rice, B. A., Kupferman, A. E. & Foster, C. S. Immunopathology of scleritis. Ophthalmology 98, 472\u2013479 (1991).","journal-title":"Ophthalmology"},{"key":"BFnrrheum2013185_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/bjo.78.5.381","volume":"78","author":"W Bernauer","year":"1994","unstructured":"Bernauer, W., Watson, P. G., Daicker, B. & Lightman, S. Cells perpetuating the inflammatory response in scleritis. Br. J. Ophthalmol. 78, 381\u2013385 (1994).","journal-title":"Br. J. Ophthalmol."},{"key":"BFnrrheum2013185_CR16","first-page":"653","volume":"150","author":"N Di Girolamo","year":"1997","unstructured":"Di Girolamo, N., Lloyd, A., McCluskey, P., Filipic, M. & Wakefield, D. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am. J. Pathol. 150, 653\u2013666 (1997).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum2013185_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ajo.2007.09.024","volume":"145","author":"P Lin","year":"2008","unstructured":"Lin, P., Bhullar, S. S., Tessler, H. H. & Goldstein, D. A. Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis. Am. J. Ophthalmol. 145, 463\u2013471 (2008).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrrheum2013185_CR18","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1002\/art.38017","volume":"65","author":"D Demoruelle","year":"2013","unstructured":"Demoruelle, D. et al. Performance of anti-cyclic citrullinated peptide assays differs in subjects at increased risk of rheumatoid arthritis and subjects with established disease. Arthritis Rheum. 65, 2243\u20132252 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013185_CR19","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","volume":"130","author":"DA Jabs","year":"2000","unstructured":"Jabs, D. A. et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am. J. Ophthalmol. 130, 492\u2013513 (2000).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrrheum2013185_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ophtha.2011.07.043","volume":"119","author":"M Sainz de la Maza","year":"2012","unstructured":"Sainz de la Maza, M. et al. Scleritis therapy. Ophthalmology 119, 51\u201358 (2012).","journal-title":"Ophthalmology"},{"key":"BFnrrheum2013185_CR21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/00003226-199507000-00010","volume":"14","author":"EM Messmer","year":"1995","unstructured":"Messmer, E. M. & Foster, C. S. Destructive corneal and scleral disease associated with rheumatoid arthritis. Medical and surgical management. Cornea 14, 408\u2013417 (1995).","journal-title":"Cornea"},{"key":"BFnrrheum2013185_CR22","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ophtha.2009.06.060","volume":"117","author":"SS Pujari","year":"2010","unstructured":"Pujari, S. S. et al. Cyclophosphamide for ocular inflammatory diseases. Ophthalmology 117, 356\u2013365 (2010).","journal-title":"Ophthalmology"},{"key":"BFnrrheum2013185_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ajo.2007.11.010","volume":"145","author":"AW Jachens","year":"2008","unstructured":"Jachens, A. W. & Chu, D. S. Retrospective review of methotrexate therapy in the treatment of chronic, noninfectious, nonnecrotizing scleritis. Am. J. Ophthalmol. 145, 487\u2013492 (2008).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrrheum2013185_CR24","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.ophtha.2008.04.026","volume":"115","author":"A Galor","year":"2008","unstructured":"Galor, A. et al. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Ophthalmology 115, 1826\u20131832 (2008).","journal-title":"Ophthalmology"},{"key":"BFnrrheum2013185_CR25","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0161-6420(03)00570-0","volume":"110","author":"HN Sen","year":"2003","unstructured":"Sen, H. N. et al. Mycophenolate mofetil for the treatment of scleritis. Ophthalmology 110, 1750\u20131755 (2003).","journal-title":"Ophthalmology"},{"key":"BFnrrheum2013185_CR26","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.ophtha.2007.12.011","volume":"115","author":"L Sobrin","year":"2008","unstructured":"Sobrin, L., Christen, W. & Foster, C. S. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis. Ophthalmology 115, 1416\u20131421 (2008).","journal-title":"Ophthalmology"},{"key":"BFnrrheum2013185_CR27","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.ophtha.2005.02.020","volume":"112","author":"JE Thorne","year":"2005","unstructured":"Thorne, J. E. et al. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology 112, 1472\u20131477 (2005).","journal-title":"Ophthalmology"},{"key":"BFnrrheum2013185_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/bjo.2008.150961","volume":"94","author":"P Doctor","year":"2010","unstructured":"Doctor, P. et al. Infliximab for the treatment of refractory scleritis. Br. J. Ophthalmol. 94, 579\u2013583 (2010).","journal-title":"Br. J. Ophthalmol."},{"key":"BFnrrheum2013185_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/1529-0131(200106)45:3<252::AID-ART257>3.0.CO;2-5","volume":"45","author":"JR Smith","year":"2001","unstructured":"Smith, J. R. et al. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum. 45, 252\u2013257 (2001).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013185_CR30","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0161-6420(03)00721-8","volume":"111","author":"CC Murphy","year":"2004","unstructured":"Murphy, C. C. et al. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis. Ophthalmology 111, 352\u2013356 (2004).","journal-title":"Ophthalmology"},{"key":"BFnrrheum2013185_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/01.rhu.0000249766.24780.95","volume":"12","author":"II Atchia","year":"2006","unstructured":"Atchia, I. I., Kidd, C. E. & Bell, R. W. D. Rheumatoid arthritis-associated necrotizing scleritis and peripheral ulcerative keratitis treated successfully with infliximab. J. Clin. Rheumatol. 12, 291\u2013293 (2006).","journal-title":"J. Clin. Rheumatol."},{"key":"BFnrrheum2013185_CR32","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/rheumatology\/keh635","volume":"44","author":"D Ashok","year":"2005","unstructured":"Ashok, D., Ayliffe, W. H. & Kiely, P. D. W. Necrotizing scleritis associated with rheumatoid arthritis: long-term remission with high-dose infliximab therapy. Rheumatology (Oxford) 44, 950\u2013951 (2005).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2013185_CR33","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/rheumatology\/kem052","volume":"46","author":"C Botsios","year":"2007","unstructured":"Botsios, C., Sfriso, P., Ostuni, P. A., Todesco, S. & Punzi, L. Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis. Report of two cases. Rheumatology (Oxford) 46, 1042\u20131043 (2007).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2013185_CR34","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1136\/bjo.2008.147157","volume":"93","author":"S Chauhan","year":"2009","unstructured":"Chauhan, S., Kamal, A, Thompson, R. N., Estrach, C. & Moots, R. J. Rituximab for treatment of scleritis associated with rheumatoid arthritis. Br. J. Ophthalmol. 93, 984\u2013985 (2009).","journal-title":"Br. J. Ophthalmol."},{"key":"BFnrrheum2013185_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.oftal.2011.01.003","volume":"86","author":"M Albert","year":"2011","unstructured":"Albert, M., Beltr\u00e1n, E. & Mart\u00ednez-Costa, L. Rituximab in rheumatoid arthritis-associated peripheral ulcerative keratitis [Spanish]. Arch. Soc. Esp. Oftalmol. 86, 118\u2013120 (2011).","journal-title":"Arch. Soc. Esp. Oftalmol."},{"key":"BFnrrheum2013185_CR36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/09273941003739928","volume":"18","author":"B Iaccheri","year":"2010","unstructured":"Iaccheri, B. et al. Rituximab treatment for persistent scleritis associated with rheumatoid arthritis. Ocul. Immunol. Inflamm. 18, 223\u2013225 (2010).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"BFnrrheum2013185_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1001\/archopht.120.1.15","volume":"120","author":"M Sainz de la Maza","year":"2002","unstructured":"Sainz de la Maza, M., Foster, C. S., Jabbur, N. S. & Baltatzis, S. Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy. Arch. Ophthalmol. 120, 15\u201319 (2002).","journal-title":"Arch. Ophthalmol."},{"key":"BFnrrheum2013185_CR38","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1136\/bjo.83.8.941","volume":"83","author":"M McKibbin","year":"1999","unstructured":"McKibbin, M., Isaacs, J. D. & Morrell, A. J. Incidence of corneal melting in association with systemic disease in the Yorkshire region, 1995\u20137. Br. J. Opthalmol. 83, 941\u2013943 (1999).","journal-title":"Br. J. Opthalmol."},{"key":"BFnrrheum2013185_CR39","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/rheumatology\/38.12.1245","volume":"38","author":"DM Squirrell","year":"1999","unstructured":"Squirrell, D. M., Winfield, J. & Amos, R. S. Peripheral ulcerative keratitis 'corneal melt' and rheumatoid arthritis: a case series. Rheumatology (Oxford) 38, 1245\u20131248 (1999).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2013185_CR40","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1136\/bjo.68.3.182","volume":"68","author":"PI Murray","year":"1984","unstructured":"Murray, P. I. & Rahi, A. H. Pathogenesis of Mooren's ulcer: some new concepts. Br. J. Ophthalmol. 68, 182\u2013187 (1984).","journal-title":"Br. J. Ophthalmol."},{"key":"BFnrrheum2013185_CR41","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0039-6257(98)00051-4","volume":"43","author":"EM Messmer","year":"1999","unstructured":"Messmer, E. M. & Foster, C. S. Vasculitic peripheral ulcerative keratitis. Surv. Ophthalmol. 43, 379\u2013396 (1999).","journal-title":"Surv. Ophthalmol."},{"key":"BFnrrheum2013185_CR42","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/eye.1992.136","volume":"6","author":"SL John","year":"1992","unstructured":"John, S. L., Morgan, K., Tullo, A. B. & Holt, P. J. Corneal autoimmunity in patients with peripheral ulcerative keratitis (PUK) in association with rheumatoid arthritis and Wegener's granulomatosis. Eye (Lond.) 6, 630\u2013636 (1992).","journal-title":"Eye (Lond.)"},{"key":"BFnrrheum2013185_CR43","unstructured":"Dana, M. R., Qian, Y. & Hamrah, P. Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection."},{"key":"BFnrrheum2013185_CR44","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/eye.1995.182","volume":"9","author":"GP Riley","year":"1995","unstructured":"Riley, G. P., Harrall, R. L., Watson, P. G., Cawston, T. E. & Hazleman, B. L. Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye (Lond.) 9, 703\u2013718 (1995).","journal-title":"Eye (Lond.)"},{"key":"BFnrrheum2013185_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/bjo.85.2.147","volume":"85","author":"VA Smith","year":"2001","unstructured":"Smith, V. A., Rishmawi, H., Hussein, H. & Easty, D. L. Tear film MMP accumulation and corneal disease. Br. J. Ophthalmol. 85, 147\u2013153 (2001).","journal-title":"Br. J. Ophthalmol."},{"key":"BFnrrheum2013185_CR46","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/ard.2004.023283","volume":"64","author":"AR Clewes","year":"2005","unstructured":"Clewes, A. R., Dawson, J. K., Kaye, S. & Bucknall, R. C. Peripheral ulcerative keratitis in rheumatoid arthritis: successful use of intravenous cyclophosphamide and comparison of clinical and serological characteristics. Ann. Rheum. Dis. 64, 961\u2013962 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2013185_CR47","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/01.ico.0000154391.28254.1d","volume":"24","author":"JW Thomas","year":"2005","unstructured":"Thomas, J. W. & Pflugfelder, S. C. Therapy of progressive rheumatoid arthritis-associated corneal ulceration with infliximab. Cornea 24, 742\u2013744 (2005).","journal-title":"Cornea"},{"key":"BFnrrheum2013185_CR48","first-page":"173793","volume":"2012","author":"SF Antao","year":"2012","unstructured":"Antao, S. F., Ayoub, T., Tahir, H. & Parmar, D. N. Stabilization of bilateral progressive rheumatoid corneal melt with infliximab. Case Rep. Ophthalmol. Med. 2012, 173793 (2012).","journal-title":"Case Rep. Ophthalmol. Med."},{"key":"BFnrrheum2013185_CR49","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00296-009-1161-7","volume":"30","author":"BL Silva","year":"2010","unstructured":"Silva, B. L. et al. Peripheral ulcerative keratitis: a serious complication of rheumatoid arthritis. Rheumatol. Int. 30, 1267\u20131268 (2010).","journal-title":"Rheumatol. Int."},{"key":"BFnrrheum2013185_CR50","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/ard.53.10.637","volume":"53","author":"C Vitali","year":"1994","unstructured":"Vitali, C., Moutsopoulos, H. M. & Bombardieri, S. The European Community Study Group on diagnostic criteria for Sj\u00f6gren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sj\u00f6gren's syndrome. Ann. Rheum. Dis. 53, 637\u2013647 (1994).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2013185_CR51","first-page":"1098","volume":"14","author":"AP Andonopoulos","year":"1987","unstructured":"Andonopoulos, A. P., Drosos, A. A., Skopouli, F. N., Acritidis, N. C. & Moutsopoulos, H. M. Secondary Sj\u00f6gren's syndrome in rheumatoid arthritis. J. Rheumatol. 14, 1098\u20131103 (1987).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2013185_CR52","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/ard.58.7.415","volume":"58","author":"T Uhlig","year":"1999","unstructured":"Uhlig, T., Kvien, T. K., Jensen, J. L. & Ax\u00e9ll, T. Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis. Ann. Rheum. Dis. 58, 415\u2013422 (1999).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2013185_CR53","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/art.10999","volume":"49","author":"JG Brun","year":"2003","unstructured":"Brun, J. G., Madland, T. M. & Jonsson, R. A prospective study of sicca symptoms in patients with rheumatoid arthritis. Arthritis Rheum. 49, 187\u2013192 (2003).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013185_CR54","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/msc.104","volume":"5","author":"H Piper","year":"2007","unstructured":"Piper, H. et al. Prevalence and predictors of ocular manifestations of RA: is there a need for routine screening? Musculoskeletal. Care 5, 102\u2013117 (2007).","journal-title":"Musculoskeletal. Care"},{"key":"BFnrrheum2013185_CR55","first-page":"221","volume":"21","author":"MA Lemp","year":"1995","unstructured":"Lemp, M. A. Report of the National Eye Institute\/Industry workshop on Clinical Trials in Dry Eyes. CLAO J. 21, 221\u2013232 (1995).","journal-title":"CLAO J."},{"key":"BFnrrheum2013185_CR56","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/archinte.159.2.174","volume":"159","author":"FB Vivino","year":"1999","unstructured":"Vivino, F. B. et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sj\u00f6gren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92\u201301 Study Group. Arch. Intern. Med. 159, 174\u2013181 (1999).","journal-title":"Arch. Intern. Med."},{"key":"BFnrrheum2013185_CR57","unstructured":"US Department of Health & Human Services. Salogen\u00ae Tablets. US Food and Drug Administration [online] , (2013)."},{"key":"BFnrrheum2013185_CR58","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.ophtha.2010.12.016","volume":"118","author":"EK Akpek","year":"2011","unstructured":"Akpek, E. K. et al. Treatment of Sj\u00f6gren's syndrome-associated dry eye an evidence-based review. Ophtalmology 118, 1242\u20131252 (2011).","journal-title":"Ophtalmology"},{"key":"BFnrrheum2013185_CR59","unstructured":"US Department of Health & Human Services. Restasis\u00ae. US Food and Drug Administration [online] , (2013)."},{"key":"BFnrrheum2013185_CR60","doi-asserted-by":"publisher","unstructured":"Kruh, J. N., Yang, P., Suelves, A. M. & Foster, C. S. Infliximab for the treatment of refractory noninfectious uveitis: a study of 88 patients with long-term follow-up. Opthalmology http:\/\/dx.doi.org\/10.1016\/j.ophtha.2013.07.019 .","DOI":"10.1016\/j.ophtha.2013.07.019"},{"key":"BFnrrheum2013185_CR61","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1136\/ard.2006.052092","volume":"65","author":"S Guignard","year":"2006","unstructured":"Guignard, S. et al. Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study. Ann. Rheum. Dis. 65, 1631\u20131634 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2013185_CR62","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/ard.2008.092585","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit, M. et al. Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study. Ann. Rheum. Dis. 68, 696\u2013701 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2013185_CR63","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/ard.2008.103192","volume":"69","author":"J Sieper","year":"2010","unstructured":"Sieper, J. et al. Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials. Ann. Rheum. Dis. 69, 226\u2013229 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2013185_CR64","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1002\/art.21197","volume":"52","author":"J Braun","year":"2005","unstructured":"Braun, J., Baraliakos, X., Listing, J. & Sieper, J. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum. 52, 2447\u20132451 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013185_CR65","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.semarthrit.2011.05.005","volume":"41","author":"D Wendling","year":"2011","unstructured":"Wendling, D. et al. New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases. Semin. Arthritis Rheum. 41, 503\u2013510 (2011).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrrheum2013185_CR66","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000289205","volume":"11","author":"PP Sfikakis","year":"2010","unstructured":"Sfikakis, P. P. The first decare of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Curr. Dir. Autoimmun. 11, 180\u2013210 (2010).","journal-title":"Curr. Dir. Autoimmun."},{"key":"BFnrrheum2013185_CR67","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.3899\/jrheum.110170","volume":"38","author":"D Wendling","year":"2011","unstructured":"Wendling, D., Dernis, E., Prati, C., Frisch, E. & Delbosc, B. Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect? J. Rheumatol. 38, 2284 (2011).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2013185_CR68","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/rheumatology\/kep390","volume":"49","author":"L-A Goodisson","year":"2010","unstructured":"Goodisson, L.-A., Bourne, J. T. & Maharajan, S. A case of bilateral peripheral ulcerative keratitis following treatment with rituximab. Rheumatology (Oxford) 49, 609\u2013610 (2010).","journal-title":"Rheumatology (Oxford)"}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2013.185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2013.185","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2013.185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T22:00:03Z","timestamp":1688853603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2013.185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,10]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["BFnrrheum2013185"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2013.185","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,10]]}}}